enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Category : Drugs developed by Takeda Pharmaceutical Company

   en.wikipedia.org/wiki/Category:Drugs_developed...

   Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more

3. Takeda Pharmaceutical Company - Wikipedia

   en.wikipedia.org/wiki/Takeda_Pharmaceutical_Company

   Takeda Midosuji Building, headquarters of Takeda Pharmaceutical Company, in Chuo-ku, Osaka, Japan. Takeda Pharmaceuticals was founded in 1781, and was incorporated on January 29, 1925. [12] One of the firm's mainstay drugs is Actos (pioglitazone), a compound in the thiazolidinedione class of drugs used in the treatment of type 2 diabetes. It ...

4. TAP Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/TAP_Pharmaceuticals

   The first products TAP file new drug applications for, were two cephalosporins, cefmenoxime (Cefmax) and cefsulodin (Cefonomil), estazolam for sleep disorders, and leuprorelin; leuprorelin was the first one approved, in 1985. [3] In 1998 Takeda established its own US R&D and sales force, for the diabetes drug pioglitazone (Actos). [1]

5. Soticlestat - Wikipedia

   en.wikipedia.org/wiki/Soticlestat

   Soticlestat (TAK-935, OV-935) is an experimental anticonvulsant and cholesterol 24-hydroxylase inhibitor being investigated as a treatment for Dravet syndrome, Lennox–Gastaut syndrome, tuberous sclerosis complex, dup15q syndrome, and CDKL5 deficiency disorder.

6. Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth ...

   www.aol.com/finance/japans-takeda-pharma...

   On Thursday, Japan’s drugmaker Takeda Pharmaceutical Company Limited (NYSE:TAK) announced a restructuring after the company reported a fiscal year 2023 net profit of 144 billion yen (around $954 ...

7. Mifamurtide - Wikipedia

   en.wikipedia.org/wiki/Mifamurtide

   Mifamurtide (trade name Mepact, marketed by Takeda) is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in over half of cases. The drug was approved in Europe in March 2009.

8. Continuity of Care Document - Wikipedia

   en.wikipedia.org/wiki/Continuity_of_Care_Document

   The patient summary contains a core data set of the most relevant administrative, demographic, and clinical information facts about a patient's healthcare, covering one or more healthcare encounters. It provides a means for one healthcare practitioner, system, or setting to aggregate all of the pertinent data about a patient and forward it to ...

9. Expanded access - Wikipedia

   en.wikipedia.org/wiki/Expanded_access

   Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of investigational new drug applications (IND) or IDE application for devices, outside of a clinical trial, by people with serious or life-threatening conditions who do not meet the enrollment criteria for the clinical trial in progress.